13.63 USD
↘ 0.36 (2.54%)AT CLOSE (11:59 AM EDT)
Cybin Inc. Common Stock
HELPNASDAQ • USD
13.81
↗ 0.17 (1.28%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
13.81
↗ 0.17 (1.28%)
Market: CLOSED
Shares of Cybin Inc. Common Stock (HELP) are trading at $13.62. The technical outlook is "Strong Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 26, 2026.
Open?$14.19
High?$14.28
Low?$13.59
Prev. Close?$13.99
Volume?1.6M
Avg. Volume?N/A
VWAP?$13.90
Bid / Ask
Bid?$13.65 × 300
Ask?$13.85 × 100
Spread?$0.20
Midpoint?$13.75
Valuation & Ratios
Market Cap?1.0B
Shares Out?73.1M
Float?50.1M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?6.39%Elevated
Short Interest?3.2M
Days to Cover?1.4
Free Float50.1M
Avg Daily Volume2.3M
Settlement Date2026-08-14